Fig. 4

Effects of QD and its active components administration on UC mice (n = 5). (A) The protocol of UC modeling and intervention. (B) Appearance and relative changes of body weight in each group. (C) Perianal condition and changes of DAI score in each group. (D) Length of colon in each group. (E) The pathological observation (H&E staining) and TDI score in each group. (F) The pathological observation (PAS staining) and the number of goblet cells. (∗P value < 0.05)